FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ranitidine (Zantac) Tablets
Status: Discontinuation
»Therapeutic Categories: Gastroenterology

Expand all

GlaxoSmithKline (New 09/01/2017)

Company Contact Information:
908-293-5330

Presentation Posting Date Related Information
150 mg tablets; 60-count bottles (NDC 0173-0344-42) 09/01/2017 A business decision was made to discontinue manufacture of the drug product.
300 mg tablets; 30-count bottles (NDC 0173-0393-40) 09/01/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is July 31, 2018.

Sandoz (New 09/08/2017)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
60 count container (NDC 0781-18-8360) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg.
1000 count container (NDC 0781-18-8310) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg.
30 count container (NDC 0781-18-8431) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg.
250 count container (NDC 0781-18-8425) 09/08/2017 Sandoz has made a business decision to permanently discontinue Ranitidine Tablets 150mg and 300mg.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English